Table 2.
Clinical findings of the RP patients
| Case | Sex/age | Disease duration (years) | Disease activity | Disease manifestations | Treatment (mg) | Duration of treatment (years) | ESR (mm/ h) |
|---|---|---|---|---|---|---|---|
| 1 | 47/F | 2 | Remission | au + n + ey + ar + ie | P (10), AZP (–) | 0·5 | 8 |
| 2 | 66/F | 7 | Remission | n + ey + ie | P (11) | 6 | 9 |
| 3 | 33/M | 1 | Remission | au + ey + ar | – | – | 26 |
| 4 | 48/F | 0·1 | Active | au + ey + n + tr + ie | P (17) | 0 | 92 |
| 5 | 43/F | 4 | Remission | au + ey + ie | P (7) | 4 | 8 |
| 6 | 61/F | 4 | Remission | au + ey + ar | – | 4 | 8 |
| 7 | 39/F | 1 | Active | n + ar + tr | P (9) | 0·7 | 13 |
| 8 | 55/M | 2 | Active | au + ar + ie + tr | P (20) | 1 | 34 |
| 9 | 36/M | 0·3 | Active | au + ey + n | P (10), CYC (25) | 0 | 57 |
| 10 | 70/M | 0·3 | Active | au + ey + ie | – | – | 120 |
ESR = erythrocyte sedimentation rate; au = auricle; n = nose; ey = eye; ar = arthritis; tr = trachea, i.e. = inner ear; P = prednisolone; AZP = azathioprine; CYC = cyclophosphamide.